Operating
Gain (Loss) on Investments
Roivant Sciences Gain (Loss) on Investments decreased by 83.2% to $21.59M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 201.3%, from -$21.31M to $21.59M.
Analysis
StatementCash Flow Statement
SectionOperating
First reportedQ1 2020
Last reportedQ3 2025Feb 6, 2026
Metric ID:
operating_gain_loss_on_investmentsHistorical Data
17 periods
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$8.62M | $32.27M | -$38.04M | -$72.91M | -$24.55M | -$54.68M | $25.95M | -$7.56M | -$45.85M | -$10.47M | $15.23M | $48.38M | -$21.31M | $12.90M | -$19.13M | $128.50M | $21.59M |
| QoQ Change | — | +474.4% | -217.9% | -91.7% | +66.3% | -122.7% | +147.5% | -129.2% | -506.1% | +77.2% | +245.5% | +217.7% | -144.1% | +160.5% | -248.3% | +771.9% | -83.2% |
| YoY Change | — | — | — | — | -184.8% | -269.4% | +168.2% | +69.2% | +16.1% | -140.3% | +301.3% | +205.5% | -103.6% | — | -225.6% | +165.6% | +201.3% |
Range-$72.91M – $128.50M
CAGR+25.8%
Avg YoY Growth+17.0%
Median YoY Growth+42.7%
Business Segments
| Segment | Q2 '25 | Q3 '25 |
|---|---|---|
| Reportable Segment | $128.50M | $21.59M |
| Total | $128.50M | $21.59M |
Gain (Loss) on Investments at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's gain (loss) on investments?
- Roivant Sciences (ROIV) reported gain (loss) on investments of $21.59M in Q4 2025.
- How has Roivant Sciences's gain (loss) on investments changed year-over-year?
- Roivant Sciences's gain (loss) on investments increased by 201.3% year-over-year, from -$21.31M to $21.59M.